Hundreds of millions of VC funding are being funneled into regenerative medicine. The goal: To extend life to previously unattainable limits.
Last time on DiffuseTap, Mike Moradi, Managing Member at R3 Bio, talked to us about regenerative medicine and what it is, current trends and investment opportunities in this space in the aftermath of COVID, and how VCs should place their bets to avoid the potentially expensive pitfalls in the space.
Listen to the full audio now or download the event transcript here.
